510(k) K811777
K811777 is an FDA 510(k) premarket notification submitted by Helena Laboratories for the device "HELENA PLASMINOGEN QUIPLATE PROCEDURE". The FDA issued a decision of Substantially Equivalent on July 2, 1981. The device falls under product code DDX (Plasminogen, Antigen, Antiserum, Control), a Class I device regulated under 21 CFR 866.5715. Helena Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 2, 1981
- Date Received
- June 23, 1981
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Plasminogen, Antigen, Antiserum, Control
- Device Class
- Class I
- Regulation Number
- 866.5715
- Review Panel
- HE
- Submission Type